BE-O12 Biomolecular engineering of human lectin galectin-2(Section V Biomolecular Engineering and Bioseparation)
スポンサーリンク
概要
著者
-
Middelberg Anton
The University of Queensland
-
Wang Hui
The University of Queensland, Australian Institute for Bioengineering and Nanotechnology, Centre for
-
He Lizhong
The University of Queensland, Australian Institute for Bioengineering and Nanotechnology, Centre for
-
Lensch Martin
Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University
-
Gabius Hans-Joachim
Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University
-
Fee Conan
Department of Chemical and Process Engineering, University of Canterbury
-
Gabius Hans-joachim
Institute Of Physiological Chemistry Faculty Of Veterinary Medicine Ludwig-maximilians-university
-
Gabius Hans-joachim
Institute For Physiological Chemistry Ludwig-maximilians-university
-
He Lizhong
The University Of Queensland Australian Institute For Bioengineering And Nanotechnology Centre For B
-
Lensch Martin
Institute Of Physiological Chemistry Faculty Of Veterinary Medicine Ludwig-maximilians-university
-
Fee Conan
Department Of Chemical And Process Engineering University Of Canterbury
-
Wang Hui
The University Of Queensland Australian Institute For Bioengineering And Nanotechnology Centre For B
-
Middelberg Anton
The University Of Queensland Australian Institute For Bioengineering And Nanotechnology Centre For B
関連論文
- BE-P14 Terahertz and conventional analysis of virus-like particle vaccines(Section V Biomolecular Engineering and Bioseparation)
- BE-O12 Biomolecular engineering of human lectin galectin-2(Section V Biomolecular Engineering and Bioseparation)
- BE-O7 Biomolecular engineering for recombinant sustainable surfactants(Section V Biomolecular Engineering and Bioseparation)
- 糖鎖導入ドラッグデリバリー材料開発のためのネオ糖タンパク質・リポソームコンジュゲートの調製と機能評価
- Localized fibrous tumors (LFTs) of the pleura : Clinical data, asbestos burden, and syntactic structure analysis applied to newly defined angiogenic/growth-regulatory effectors